In SH‐SY5Y and mouse primary cells, we have demonstrated that an increased phosphorylation of tau by kinase GSK3β, as occurs in Alzheimer disease, can modulate the levels and enzymatic activity of cholinergic AChE. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.